Research references

Endocannabinoid system dysfunction in mood and related disorders:

https://www.ncbi.nlm.nih.gov/pubmed/21916860

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives:

https://www.ncbi.nlm.nih.gov/pubmed/21693551

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa:

https://www.ncbi.nlm.nih.gov/pubmed/24923339

The endocannabinoid system and the treatment of mood and anxiety disorders:

https://www.ncbi.nlm.nih.gov/pubmed/19839936

Endocannabinoid signaling in the etiology and treatment of major depressive illness:

https://www.ncbi.nlm.nih.gov/pubmed/24180398

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L:

https://www.ncbi.nlm.nih.gov/pubmed/20332000

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants:

https://www.ncbi.nlm.nih.gov/pubmed/19732971

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors:

https://www.ncbi.nlm.nih.gov/pubmed/26711860

Side effects of common psychiatric drugs:
 

https://www.cchrint.org/pdfs/The_Side_Effects_of_Common_Psychiatric_Drugs.pdf

Pregabalin associated discontinuation symptoms (A case study):

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284877/